BioNTech
phase off the shelf vaccine as and in combination with inhibitor in patients with prostate cancer median age years hypertension committee i immunogenic signs of anti tumor activity no safety signals of concern | BioNTech
Company
Deck Type
Sector
Industry
Deck date
November 2021
Slide
23 of 40
Related slides by other companies
ATAI
Investor Presentation
March 2023
summary has the potential for like rapid onset efficacy with improved safety and tolerability | ATAI
Alkermes
Investor Presentation
October 2023
artistry first in human study of global open label phase study | Alkermes
MAIA Biotechnology
Investor Presentation
July 2023
thio trial patients dosed to date | MAIA Biotechnology
Alkermes
Results
June 2022
artistry first in human study of | Alkermes
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io